| __timestamp | Apellis Pharmaceuticals, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 55962693 |
| Thursday, January 1, 2015 | 13730311 | 78655788 |
| Friday, January 1, 2016 | 22978599 | 95723069 |
| Sunday, January 1, 2017 | 40303878 | 116808575 |
| Monday, January 1, 2018 | 105285576 | 106397017 |
| Tuesday, January 1, 2019 | 220968770 | 108431600 |
| Wednesday, January 1, 2020 | 299921000 | 141426832 |
| Friday, January 1, 2021 | 420869000 | 225200000 |
| Saturday, January 1, 2022 | 387236000 | 297812160 |
| Sunday, January 1, 2023 | 354387000 | 283614139 |
In pursuit of knowledge
In the ever-evolving world of pharmaceuticals, innovation is the key to staying ahead. Over the past decade, Apellis Pharmaceuticals, Inc. and MorphoSys AG have demonstrated their commitment to research and development (R&D) with significant investments. From 2014 to 2023, Apellis Pharmaceuticals increased its R&D spending by an impressive 4,100%, peaking in 2021. Meanwhile, MorphoSys AG, with a more consistent growth trajectory, saw its R&D expenses rise by approximately 400% over the same period.
In 2021, Apellis Pharmaceuticals outspent MorphoSys AG by nearly 87%, highlighting its aggressive push towards innovation. However, by 2023, the gap narrowed, with Apellis spending only 25% more than MorphoSys. This trend suggests a competitive race in the pharmaceutical industry, where both companies are vying for breakthroughs that could redefine healthcare. As these companies continue to prioritize R&D, the future of medicine looks promising.
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
Biogen Inc. or MorphoSys AG: Who Invests More in Innovation?
R&D Spending Showdown: BeiGene, Ltd. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and MorphoSys AG
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs MorphoSys AG
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Xencor, Inc.